TransMedics Group, Inc. (TMDX) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
TransMedics Group, Inc. · Health Care · ref. ETF XLV · 77 calls · price $79.14
What the company does: TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
📈 TransMedics Group, Inc. (TMDX) stock price
$79.14-28.9% over range
Oct 14, 25low $62.04 · high $150.42Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
75% recommend buying · 8 analysts
📊 JPI status : TransMedics Group, Inc. is no longer in our current JPI rankings, but appeared in the past (2025) — its upside may be behind it. See the stocks picked in 2025 →
🎯 TMDX price target & analyst consensus — price $79.14
The price target · all analysts combined (8 targets)
Highest target · 2 firms of 8$120+51.6%
Median target · of 8 targets$100+26.4%
Lowest target · 1 firm of 8$77-2.7%
Current price$79.14
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
788%
$80 ↔ $120
Below
113%
$77
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: UBS — 59% of its targets hit on this sector (76 calls tested). It aims for $77 (-2.7 %), call made on August 6, 2026, maturing on August 6, 2027 (69 d ago).
The 1 reliable analyst
$77-2.7 %
The 7 other firms
$100+26 %
How to read it: the 1 reliable firms are not filtered by optimism — 0 aim above the price, 1 below, hence their $77 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 8 ratings (last 6 months)
Strong Buy00%
Buy675%
Hold225%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 TMDX price target all
All 77 calls, one by one, with our verdict on each firm.
→ See all 77 targets, analyst by analyst💡 The best analysts on TMDX most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in TMDX? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about TransMedics Group, Inc.? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on TMDX
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Baird ↗ | 67% | +38.8% | 3 |
| Canaccord Genuity ↗ | 58% | +46.0% | 12 |
| JP Morgan ↗ | 57% | +22.2% | 7 |
| Oppenheimer ↗ | 55% | +30.5% | 11 |
| TD Cowen ↗ | 50% | +36.6% | 4 |
| Cowen & Co. | 40% | +50.1% | 5 |
| Piper Sandler ↗ | 33% | +3.5% | 12 |
| Needham ↗ | 33% | -4.7% | 3 |
| Stephens & Co. ↗ | 0% | -8.5% | 2 |
📊 What $1,000 invested in TransMedics Group, Inc. would be worth › open the full page
In short — $1,000 invested in TransMedics Group, Inc. 10 years ago would be worth $3,008 today, i.e. +17%/yr on average. Best year: 2022 (+222%), worst: 2024 (-12%). Price performance, excluding dividends.
If I'd invested $1,000 in TransMedics Group, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,080 | +8% |
| 3 years ago | $1,209 | +21% |
| 5 years ago | $3,748 | +275% |
Return by year (TransMedics Group, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -39% | $608 (-39%) |
| 2025 | +78% | $1,080 (+8%) |
| 2024 | -12% | $945 (-5%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on TransMedics Group, Inc.
Loading news…
📋 All analyst calls on TMDX
Filtered on — · ✕ show all
Canaccord Genuity ↗
Oct 13, 26
▲ Buy · 🎯$94
Today : $79.14 — upside +19%
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Oct 13, 27
matures : Oct 13, 27
▲ Overweight · 🎯$120
Price at call : $81.07 — upside +48%
Today : $79.14 — upside +52%
🎯 on TMDX : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
▲ Buy · 🎯$120
Price at call : $86.4 — upside +39%
Today : $79.14 — upside +52%
🎯 on TMDX : no call matured yet · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : Sep 8, 27
matures : Sep 8, 27
■ Neutral neutral · not a buy · 🎯$77
Price at call : $80.21 — gap to target -4%
Today : $79.14 — gap to target -3%
🎯 on TMDX : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
Piper Sandler ↗
Aug 5, 26
▲ Overweight · 🎯$100
Price at call : $80.21 — upside +25%
Today : $79.14 — upside +26%
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
▲ Buy · 🎯$106
Price at call : $81.55 — upside +30%
Today : $79.14 — upside +34%
🎯 on TMDX : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Aug 3, 27
matures : Aug 3, 27
■ Neutral neutral · not a buy · 🎯$80
Price at call : $78 — gap to target +3%
Today : $79.14 — gap to target +1%
🎯 on TMDX : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$90
Price at call : $71.11 — upside +27%
Today : $79.14 — upside +14%
🎯 on TMDX : 0% (1 call matured) · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
See the other 69 calls, newest to oldest
▲ Buy · 🎯$120
Price at call : $68.86 — upside +74%
Today : $79.14 — upside +52%
🎯 on TMDX : no call matured yet · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : Jul 1, 27
matures : Jul 1, 27
Canaccord Genuity ↗
Jun 30, 26
▲ Buy · 🎯$124
Price at call : $67.85 — upside +83%
Today : $79.14 — upside +57%
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Jun 30, 27
matures : Jun 30, 27
■ Hold neutral · not a buy · 🎯$80
Price at call : $78.79 — gap to target +2%
Today : $79.14 — gap to target +1%
🎯 on TMDX : no call matured yet · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : Jun 18, 27
matures : Jun 18, 27
■ Hold neutral · not a buy · 🎯$75
Price at call : $70.15 — gap to target +7%
Today : $79.14 — gap to target -5%
🎯 on TMDX : no call matured yet · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : May 26, 27
matures : May 26, 27
Canaccord Genuity ↗
May 7, 26
▲ Buy · 🎯$124
Price at call : $72.9 — upside +70%
Today : $79.14 — upside +57%
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
▲ Buy · 🎯$120
Price at call : $72.9 — upside +65%
Today : $79.14 — upside +52%
🎯 on TMDX : no call matured yet · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
■ Hold neutral · not a buy · 🎯$85
Price at call : $72.9 — gap to target +17%
Today : $79.14 — gap to target +7%
🎯 on TMDX : no call matured yet · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Piper Sandler ↗
May 6, 26
▲ Overweight · 🎯$120
Price at call : $72.9 — upside +65%
Today : $79.14 — upside +52%
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
▲ Buy · 🎯$142
Price at call : $72.92 — upside +95%
Today : $79.14 — upside +79%
🎯 on TMDX : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$118
Price at call : $107.32 — upside +10%
Today : $79.14 — upside +49%
🎯 on TMDX : 0% (1 call matured) · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
■ Hold neutral · not a buy · 🎯$130
Price at call : $134.77 — gap to target -4%
Today : $79.14 — gap to target +64%
🎯 on TMDX : no call matured yet · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : Mar 9, 27
matures : Mar 9, 27
■ Neutral neutral · not a buy · 🎯$149
Price at call : $134.57 — gap to target +11%
Today : $79.14 — gap to target +88%
🎯 on TMDX : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Oppenheimer ↗
Feb 25, 26
▲ Outperform · 🎯$175
Price at call : $134.57 — upside +30%
Today : $79.14 — upside +121%
🎯 on TMDX : 55% (11 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Piper Sandler ↗
Feb 25, 26
▲ Overweight · 🎯$160
Price at call : $134.57 — upside +19%
Today : $79.14 — upside +102%
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Evercore ISI Group ↗
Feb 25, 26
▲ Outperform · 🎯$170
Price at call : $131.85 — upside +29%
Today : $79.14 — upside +115%
🎯 on TMDX : 0% (1 call matured) · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
▲ Buy · 🎯$174
Price at call : $131.85 — upside +32%
Today : $79.14 — upside +120%
🎯 on TMDX : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Canaccord Genuity ↗
Dec 17, 25
▲ Buy · 🎯$148
Price at call : $121.07 — upside +22%
Today : $79.14 — upside +87%
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
▲ Buy · 🎯$166
Price at call : $136.6 — upside +22%
Today : $79.14 — upside +110%
🎯 on TMDX : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Dec 8, 26
matures : Dec 8, 26
Morgan Stanley ↗
Dec 2, 25
■ Equal-Weight neutral · not a buy · 🎯$135
Price at call : $140.1 — gap to target -4%
Today : $79.14 — gap to target +71%
🎯 on TMDX : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
Canaccord Genuity ↗
Oct 30, 25
▲ Buy · 🎯$147
Price at call : $131.54 — upside +12%
Today : $79.14 — upside +86%
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Oct 30, 26
matures : Oct 30, 26
Piper Sandler ↗
Oct 30, 25
▲ Overweight · 🎯$140
Price at call : $131.54 — upside +6%
Today : $79.14 — upside +77%
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Oct 30, 26
matures : Oct 30, 26
▲ Buy · 🎯$148
Price at call : $128.91 — upside +15%
Today : $79.14 — upside +87%
🎯 on TMDX : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
Canaccord Genuity ↗
Oct 14, 25
▲ Buy · 🎯$142
Price at call : $112.61 — upside +26%
Today : $79.14 — upside +79%
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Oct 14, 26
matures : Oct 14, 26
▲ Buy · 🎯$145
Price at call : $111.71 — upside +30%
Today : $79.14 — upside +83%
Expected +30% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 0% (1 call matured) · 📊 on Health : 49.6% · +9.4% (137 calls)
-29.2%
stock -29% · XLV +20%
matured Oct 13, 26
Evercore ISI Group ↗
Sep 16, 25
▲ Outperform · 🎯$155
Price at call : $119.81 — upside +29%
Today : $79.14 — upside +96%
Expected +29% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 0% (1 call matured) · 📊 on Health : 36.4% · -8.5% (33 calls)
-27.7%
stock -28% · XLV +23%
matured Sep 16, 26
■ Hold neutral · not a buy · 🎯$115
Price at call : $104.01 — gap to target +11%
Today : $79.14 — gap to target +45%
🎯 on TMDX : no call matured yet · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : Sep 4, 26
matures : Sep 4, 26
■ Hold neutral · not a buy
🎯 on TMDX : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Aug 25, 26
matures : Aug 25, 26
Morgan Stanley ↗
Aug 1, 25
■ Equal-Weight neutral · not a buy · 🎯$123
Price at call : $128.5 — gap to target -4%
Today : $79.14 — gap to target +55%
🎯 on TMDX : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Aug 1, 26
matures : Aug 1, 26
Canaccord Genuity ↗
Jul 15, 25
▲ Buy · 🎯$142
Price at call : $113.32 — upside +25%
Today : $79.14 — upside +79%
Expected +25% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-32.9%
stock -33% · XLV +21%
matured Jul 15, 26
Oppenheimer ↗
Jun 17, 25
▲ Outperform · 🎯$150
Price at call : $124 — upside +21%
Today : $79.14 — upside +90%
Expected +21% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 55% (11 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
-36.5%
stock -36% · XLV +12%
matured Jun 17, 26
■ Hold neutral · not a buy
🎯 on TMDX : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Jun 17, 26
matures : Jun 17, 26
Piper Sandler ↗
Jun 4, 25
▲ Overweight · 🎯$145
Price at call : $135.59 — upside +7%
Today : $79.14 — upside +83%
Expected +7% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-48.8%
stock -49% · XLV +15%
matured Jun 4, 26
■ Hold neutral · not a buy
🎯 on TMDX : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Jun 3, 26
matures : Jun 3, 26
Oppenheimer ↗
May 9, 25
▲ Outperform · 🎯$130
Price at call : $118.73 — upside +9%
Today : $79.14 — upside +64%
Expected +9% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 55% (11 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
-45.8%
stock -46% · XLV +5%
matured May 9, 26
Piper Sandler ↗
May 9, 25
▲ Overweight · 🎯$125
Price at call : $118.73 — upside +5%
Today : $79.14 — upside +58%
Expected +5% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-45.8%
stock -46% · XLV +5%
matured May 9, 26
Piper Sandler ↗
Apr 29, 25
▲ Overweight · 🎯$105
Price at call : $92.01 — upside +14%
Today : $79.14 — upside +33%
Expected +14% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+9.5%
stock +10% · XLV +4%
matured Apr 29, 26
■ Hold neutral · not a buy
🎯 on TMDX : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Apr 23, 26
matures : Apr 23, 26
■ Hold neutral · not a buy
🎯 on TMDX : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Mar 26, 26
matures : Mar 26, 26
Canaccord Genuity ↗
Mar 11, 25
▲ Buy · 🎯$104
Price at call : $67.65 — upside +54%
Today : $79.14 — upside +31%
Expected +54% · Actual +91% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+90.6%
stock +91% · XLV +5%
matured Mar 11, 26
■ Hold neutral · not a buy
🎯 on TMDX : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Feb 5, 26
matures : Feb 5, 26
■ Neutral neutral · not a buy · 🎯$75
Price at call : $65.71 — gap to target +14%
Today : $79.14 — gap to target -5%
🎯 on TMDX : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Dec 17, 25
matures : Dec 17, 25
Piper Sandler ↗
Dec 11, 24
▲ Overweight · 🎯$90
Price at call : $67.36 — upside +34%
Today : $79.14 — upside +14%
Expected +34% · Actual +89% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+89.5%
stock +89% · XLV +8%
matured Dec 11, 25
Oppenheimer ↗
Dec 3, 24
▲ Outperform · 🎯$125
Price at call : $72.21 — upside +73%
Today : $79.14 — upside +58%
Expected +73% · Actual +92% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 55% (11 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
+92.0%
stock +92% · XLV +5%
matured Dec 3, 25
Piper Sandler ↗
Nov 20, 24
▲ Overweight · 🎯$110
Price at call : $79.34 — upside +39%
Today : $79.14 — upside +39%
Expected +39% · Actual +65% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+65.0%
stock +65% · XLV +7%
matured Nov 20, 25
Canaccord Genuity ↗
Nov 20, 24
▲ Buy · 🎯$104
Price at call : $77.2 — upside +35%
Today : $79.14 — upside +31%
Expected +35% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+60.4%
stock +60% · XLV +6%
matured Nov 20, 25
Piper Sandler ↗
Oct 29, 24
▲ Overweight · 🎯$180
Price at call : $81.92 — upside +120%
Today : $79.14 — upside +127%
Expected +120% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+65.8%
stock +66% · XLV -3%
matured Oct 29, 25
Oppenheimer ↗
Oct 29, 24
▲ Outperform · 🎯$125
Price at call : $88.5 — upside +41%
Today : $79.14 — upside +58%
Expected +41% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 55% (11 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
+51.8%
stock +52% · XLV -3%
matured Oct 29, 25
Canaccord Genuity ↗
Oct 29, 24
▲ Buy · 🎯$109
Price at call : $88.5 — upside +23%
Today : $79.14 — upside +38%
Expected +23% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+51.8%
stock +52% · XLV -3%
matured Oct 29, 25
Piper Sandler ↗
Oct 7, 24
▲ Overweight · 🎯$180
Price at call : $138.12 — upside +30%
Today : $79.14 — upside +127%
Expected +30% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-14.5%
stock -15% · XLV -5%
matured Oct 7, 25
Piper Sandler ↗
Aug 1, 24
▲ Overweight · 🎯$180
Price at call : $150.1 — upside +20%
Today : $79.14 — upside +127%
Expected +20% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-14.4%
stock -14% · XLV -12%
matured Aug 1, 25
Canaccord Genuity ↗
Aug 1, 24
▲ Buy · 🎯$169
Price at call : $150.1 — upside +13%
Today : $79.14 — upside +114%
Expected +13% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-14.4%
stock -14% · XLV -12%
matured Aug 1, 25
Oppenheimer ↗
Aug 1, 24
▲ Outperform · 🎯$200
Price at call : $151.51 — upside +32%
Today : $79.14 — upside +153%
Expected +32% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 55% (11 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
-20.4%
stock -20% · XLV -13%
matured Aug 1, 25
Piper Sandler ↗
Jul 15, 24
▲ Overweight · 🎯$170
Price at call : $144.35 — upside +18%
Today : $79.14 — upside +115%
Expected +18% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-19.9%
stock -20% · XLV -10%
matured Jul 15, 25
Piper Sandler ↗
Jun 21, 24
▲ Overweight · 🎯$120
Price at call : $140.51 — upside -15%
Today : $79.14 — upside +52%
Expected -15% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-9.2%
stock -9% · XLV -10%
matured Jun 21, 25
Canaccord Genuity ↗
May 1, 24
▲ Buy · 🎯$117
Price at call : $124.44 — upside -6%
Today : $79.14 — upside +48%
Expected -6% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-27.7%
stock -28% · XLV -1%
matured May 1, 25
Piper Sandler ↗
May 1, 24
▲ Overweight · 🎯$120
Price at call : $124.44 — upside -4%
Today : $79.14 — upside +52%
Expected -4% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-27.7%
stock -28% · XLV -1%
matured May 1, 25
Oppenheimer ↗
May 1, 24
▲ Outperform · 🎯$125
Price at call : $117.6 — upside +6%
Today : $79.14 — upside +58%
Expected +6% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 55% (11 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
-23.1%
stock -23% · XLV -3%
matured May 1, 25
Piper Sandler ↗
Mar 28, 24
▲ Overweight · 🎯$95
Price at call : $73.94 — upside +28%
Today : $79.14 — upside +20%
Expected +28% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 33% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-7.2%
stock -7% · XLV -2%
matured Mar 28, 25
Oppenheimer ↗
Feb 27, 24
▲ Outperform · 🎯$105
Price at call : $88.71 — upside +18%
Today : $79.14 — upside +33%
Expected +18% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 55% (11 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
-16.9%
stock -17% · XLV +1%
matured Feb 26, 25
Canaccord Genuity ↗
May 18, 23
▲ Buy · 🎯$86
Price at call : $73.48 — upside +17%
Today : $79.14 — upside +9%
Expected +17% · Actual +88% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+87.8%
stock +88% · XLV +12%
matured May 17, 24
Oppenheimer ↗
May 2, 23
▲ Outperform · 🎯$90
Price at call : $73.82 — upside +22%
Today : $79.14 — upside +14%
Expected +22% · Actual +59% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 55% (11 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
+59.3%
stock +59% · XLV +5%
matured May 1, 24
Canaccord Genuity ↗
Feb 23, 23
▲ Buy · 🎯$78
Price at call : $78.61 — upside -1%
Today : $79.14 — upside -1%
Expected -1% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-1.1%
stock -1% · XLV +14%
matured Feb 23, 24
Oppenheimer ↗
Feb 23, 23
▲ Outperform · 🎯$85
Price at call : $77.8 — upside +9%
Today : $79.14 — upside +7%
Expected +9% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 55% (11 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
+6.9%
stock +7% · XLV +14%
matured Feb 23, 24
Oppenheimer ↗
Aug 2, 22
▲ Outperform · 🎯$45
Price at call : $39.37 — upside +14%
Today : $79.14 — upside -43%
Expected +14% · Actual +122% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 55% (11 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
+122.3%
stock +122% · XLV +1%
matured Aug 2, 23
Canaccord Genuity ↗
Mar 17, 22
▲ Buy · 🎯$39
Price at call : $22.17 — upside +76%
Today : $79.14 — upside -51%
Expected +76% · Actual +231% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+230.6%
stock +231% · XLV -8%
matured Mar 17, 23
Canaccord Genuity ↗
Aug 6, 20
▲ Buy · 🎯$20
Price at call : $18.05 — upside +11%
Today : $79.14 — upside -75%
Expected +11% · Actual +78% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+77.5%
stock +78% · XLV +25%
matured Aug 6, 21
Canaccord Genuity ↗
Apr 14, 20
▲ Buy · 🎯$19
Price at call : $15.04 — upside +26%
Today : $79.14 — upside -76%
Expected +26% · Actual +83% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+83.4%
stock +83% · XLV +25%
matured Apr 14, 21
Oppenheimer ↗
Apr 7, 20
▲ Outperform · 🎯$25
Price at call : $13.61 — upside +84%
Today : $79.14 — upside -68%
Expected +84% · Actual +146% · Reason (≥ +15%) : ✓ Yes
🎯 on TMDX : 55% (11 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
+146.1%
stock +146% · XLV +29%
matured Apr 7, 21
Canaccord Genuity ↗
May 28, 19
▲ Buy · 🎯$37
Price at call : $30.14 — upside +23%
Today : $79.14 — upside -53%
Expected +23% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on TMDX : 58% (12 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-53.6%
stock -54% · XLV +14%
matured May 27, 20
Frequently asked questions
Should I buy TransMedics Group, Inc. stock?
This isn't buy advice. For TransMedics Group, Inc., the analyst consensus is "Buy", with an average price target of $100 (+26% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 67% of the time (3 calls tracked on TransMedics Group, Inc.). We show the numbers — you decide.
Is it too late to buy TransMedics Group, Inc.? How high can it go?
The most bullish analyst target on TransMedics Group, Inc. is $120 (+52% above today's price); the average is $100. That's the upside they see. Check how reliable those analysts have actually been on TransMedics Group, Inc. on our site before trusting it.
Is TransMedics Group, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 9 analysts have a real record on TransMedics Group, Inc., the best hitting 67% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Will TransMedics Group, Inc. stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will TMDX stock recover (go back up)?
Should you invest in TransMedics Group, Inc.? The case for and against
The arguments for and against, one by one, from the numbers: why invest in TMDX (and why hesitate).
What has TransMedics Group, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: TMDX performance & returns.
What is the best month to buy TMDX?
The 12 months ranked by the stock's past returns: best & worst month to buy TMDX.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX